Kelly Schoenbeck, MD
Assistant Professor
Medicine
School of Medicine

Dr. Schoenbeck is a hematologist who studies clinical outcomes in patients with hematologic malignancies with a focus on health-related quality of life in chronic myeloid neoplasms.

Awards

Show all (6) Hide

• Award Supplement, American Society of Hematology, 2021-2022
• Research Training Award for Fellows, Year 2, American Society of Hematology, 2021-2022
• Research Training Award for Fellows, American Society of Hematology, 2020-2021
• Rachel Pearline Award, UCSF Hematology & Oncology Fellowship Program, 2018
• Resident of the Month, Columbia University Internal Medicine Residency Program, 2014
• Gold Humanism Honor Society, Oregon Health and Science University (OHSU), 2011

Publications (13)

Top publication keywords:
Multiple MyelomaProtein Kinase InhibitorsImmunologic FactorsQuality of LifeRemission InductionPatient Reported Outcome MeasuresHematopoietic Stem Cell TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFrailtyParentingPhysiciansAccidental FallsBortezomibHematologic NeoplasmsNeoplasms, Plasma Cell

• Patient-Reported Functional Outcomes in Patients With Chronic Myeloid Leukemia After Stopping Tyrosine Kinase Inhibitors.
  Journal of the National Cancer Institute 2022 Schoenbeck KL, Atallah E, Lin L, Weinfurt KP, Cortes J, Deininger MWN, Kota V, Larson RA, Mauro MJ, Oehler VG, Pinilla-Ibarz J, Radich JP, Schiffer CA, Shah NP, Silver RT, Thompson JE, Flynn KE
• HSR25-174: Impact of Adverse Events on Quality of Life in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors - Results From the Survey on Humanistic Burden of Intolerance to First or Second TKIs (SHIFT) Study.
  Journal of the National Comprehensive Cancer Network : JNCCN 2025 Flynn KE, Clements J, DeMairo K, Hiller J, Wei D, Hazra NC, Constantinescu C, Meng Y, Latremouille-Viau D, Jadhav K, Marquez G, Yang D, Damon A, Sadek I, Guérin A, Schoenbeck K
• HSR25-182: Patient-Physician Communication About Adverse Events and Impact on Quality of Life to Foster Shared Decision-Making in Chronic Myeloid Leukemia.
  Journal of the National Comprehensive Cancer Network : JNCCN 2025 Flynn KE, Clements J, DeMairo K, Hiller J, Wei D, Hazra NC, Constantinescu C, Meng Y, Latremouille-Viau D, Jadhav K, Marquez G, Yang D, Damon A, Sadek I, Guérin A, Schoenbeck K
• Frailty measures in multiple myeloma: evaluating the impact on outcomes and quality-of-life in clinical trials and real-world practice.
  Leukemia & lymphoma 2024 Pianko MJ, Mian HS, Schoenbeck KL, Wildes TM
• Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies.
  Blood advances 2023 Tsang M, Bischoff K, Schoenbeck KL, Berry K, O'Riordan D, Fakhri B, Wong SW, Shah N, Olin R, Andreadis C, Vieaux J, Cohen E, Lopez NS, Mannis GN, Rabow M

Show all (8 more) Hide

• Where the Sidewalk Ends: Parenting as a Trainee during COVID-19.
  Cancer investigation 2023 Tsang M, Banerjee R, Quiroga D, Idossa D, Schoenbeck KL
• Refining frailty in relapsed or refractory multiple myeloma: adding the patient voice.
  The lancet. Healthy longevity 2022 Schoenbeck KL, Wildes TM
• Being Present 2.0: Online Mindfulness-Based Program for Metastatic Gastrointestinal Cancer Patients and Caregivers.
  Global advances in health and medicine 2021 Dragomanovich HM, Dhruva A, Ekman E, Schoenbeck KL, Kubo A, Van Blarigan EL, Borno HT, Esquivel M, Chee B, Campanella M, Philip EJ, Rettger JP, Rosenthal B, Van Loon K, Venook AP, Boscardin C, Moran P…
• Health-Related Quality of Life of Patients with Chronic Myeloid Leukemia as Measured by Patient-Reported Outcomes: Current State and Future Directions.
  Current hematologic malignancy reports 2021 Schoenbeck KL, Flynn KE
• Bortezomib in first-line therapy is associated with falls in older adults with multiple myeloma.
  Journal of geriatric oncology 2021 Schoenbeck KL, Fiala MA, Wildes TM
• Circumstances around falls in older adults with Cancer.
  Journal of geriatric oncology 2020 Tomczak U, Sattar S, Schoenbeck KL, Cordner T, Wildes TM
• Updated Perspectives on the Management of Multiple Myeloma in Older Patients: Focus on Lenalidomide.
  Clinical interventions in aging 2020 Schoenbeck KL, Wildes TM
• Advance care planning and end-of-life care for patients with hematologic malignancies who die after hematopoietic cell transplant.
  Bone marrow transplantation 2017 Eckhert EE, Schoenbeck KL, Galligan D, McNey LM, Hwang J, Mannis GN